Page last updated: 2024-11-03

practolol and Metaplasia

practolol has been researched along with Metaplasia in 1 studies

Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.

Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.

Research Excerpts

ExcerptRelevanceReference
"Keratoconjunctivitis sicca, conjunctival scarring, fibrosis, metaplasia, and shrinkage developed in 27 patients as an adverse reaction to practolol."7.65Untoward effects associated with practolol administration: oculomucocutaneous syndrome. ( Wright, P, 1975)
"Keratoconjunctivitis sicca, conjunctival scarring, fibrosis, metaplasia, and shrinkage developed in 27 patients as an adverse reaction to practolol."3.65Untoward effects associated with practolol administration: oculomucocutaneous syndrome. ( Wright, P, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wright, P1

Other Studies

1 other study available for practolol and Metaplasia

ArticleYear
Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
    British medical journal, 1975, Mar-15, Volume: 1, Issue:5958

    Topics: Adult; Aged; Blindness; Cochlea; Conjunctiva; Ear Diseases; Eye Diseases; Female; Humans; Keratoconj

1975